PA
EXAS

Procyon Advisors’s Exact Sciences EXAS Stock Holding History

Procyon Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,096
Closed -$211K – 510
2023
Q3 		$211K Buy
+3,096
New +$263K 0.02% 449
2020
Q3 		– Sell
-3
Closed – – 457
2020
Q2 		$0 Hold
3
– – ﹤0.01% 1102
2020
Q1 		$0 Hold
3
– – ﹤0.01% 1045
2019
Q4 		$0 Buy
+3
New +$264 ﹤0.01% 1013

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Procyon Advisors's EXAS Position: Q4 2023 in Review

Procyon Advisors sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 3,096 shares — an estimated $211K sold.

Procyon Advisors first reported a position in EXAS in Q4 2019 and held it in 4 quarters. The position peaked at $211K in Q3 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Procyon Advisors reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Procyon Advisors sold 3,096 Exact Sciences shares in Q4 2023, an estimated $211K.
  • Procyon Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 4 quarters.
  • Procyon Advisors's Exact Sciences position peaked at $211K in Q3 2023.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Procyon Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.